Cargando…
Correction to: Antibody–Drug Conjugate Revolution in Breast Cancer: The Road Ahead
Autores principales: | Grinda, Thomas, Rassy, Elie, Pistilli, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122622/ https://www.ncbi.nlm.nih.gov/pubmed/37069449 http://dx.doi.org/10.1007/s11864-023-01092-1 |
Ejemplares similares
-
Antibody–Drug Conjugate Revolution in Breast Cancer: The Road Ahead
por: Grinda, Thomas, et al.
Publicado: (2023) -
Antibody drug conjugates targeting HER2: Clinical development in metastatic breast cancer
por: Rassy, Elie, et al.
Publicado: (2022) -
The EV revolution: The road ahead for critical raw materials demand
por: Jones, Ben, et al.
Publicado: (2020) -
Correction to: Circular Economy Research in the COVID-19 Era: A Review and the Road Ahead
por: Rejeb, Abderahman, et al.
Publicado: (2023) -
Are ERBB2 mutations a ‘ready for routine use’ target in patients with metastatic breast cancer?
por: Grinda, T., et al.
Publicado: (2023)